David-Silva, A., Esteves, J. V., Morais, M. R. P. T., Freitas, H. S., Zorn, T. M., Correa-Giannella, M. L., & Machado, U. F. (2020). Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice. Diabetes Metab Syndr Obes.

David-Silva, Aline, João Victor Esteves, Mychel Raony P T. Morais, Helayne Soares Freitas, Telma Maria Zorn, Maria Lucia Correa-Giannella, and Ubiratan Fabres Machado. "Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice." Diabetes Metab Syndr Obes 2020.

David-Silva, Aline, et al. "Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice." Diabetes Metab Syndr Obes 2020.